Clinical Trial Update: Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated interleukin-12 in patients with refractory advanced-stage ovarian cancer or abdominal cancer and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Ovarian Cancer

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer | Phase 1 | Status: COMPLETED